Orlando, United States
Fountain Life, founded in 2019 and headquartered in the United States, has carved a niche in the AI and Health and Wellness sectors with its mission to extend human longevity. Self-styled as "The world’s leading science-backed longevity membership, powered by AI," the company leverages advanced diagnostics, personalized health plans, and cutting-edge therapeutics to add healthy decades to its members’ lives.
Bolstered by a $18.00M Series B investment in August 2025 from notable investors like EOS Ventures, Peter Diamandis, and Tony Robbins, Fountain Life is poised for growth. The company's business model aligns with increasing global demand for AI-driven healthcare solutions, particularly in the ambit of preventive care—a promising market with substantial potential.
The clear focus on longevity solutions underpinned by AI positions Fountain Life as a forward-thinking player in a burgeoning industry, capturing the ethos of those who refuse to settle and aim to push human potential.
